Cost-Offsets of New Medications for Treatment of Schizophrenia [PDF]
Broad claims are frequently made that new medications will offset all or part of their costs by reducing other areas of Medicaid spending. In this paper we examine the net impact on spending for new drugs used to treat schizophrenia.
Richard G. Frank+2 more
core
Sex Differences in Aripiprazole Sensitization from Adolescence to Adulthood [PDF]
The present study investigated the potential sex differences in repeated aripiprazole (ARI) treatment-induced behavioral sensitization from adolescence to adulthood, and to determine whether ARI sensitization can be transferred to olanzapine (OLZ) and/or
Chow, Shinnyi+4 more
core +1 more source
Clozapine as add-on medication in the maintenance treatment of bipolar and schizoaffective disorders - A case series [PDF]
Atypical neuroleptics are increasingly used in the treatment of bipolar and schizoaffective disorders. Currently, numerous controlled short-term studies are available for clozapine, olanzapine, risperidone or quetiapine, but long-term data are still ...
Amann, B.+5 more
core +1 more source
Safety and Effect of 12‐Month Ecopipam Treatment in Pediatric Patients with Tourette Syndrome
Abstract Background Tourette syndrome (TS) is a chronic neurodevelopmental tic disorder with a considerable quality of life (QOL) burden. Objectives The goal was to determine the long‐term safety, tolerability, and clinical effects of ecopipam, a first‐in‐class dopamine D1 receptor antagonist, for TS.
Donald L. Gilbert+7 more
wiley +1 more source
Purpose: The objective of this study was to document the prevalence of high blood pressure (BP) and to explore its relationship with weight among inpatients with schizophrenia.
Yu-Li Lan, PhD, Tzy-Ling Chen, PhD
doaj +1 more source
Patient and Healthcare Professional Preferences for Characteristics of Long-Acting Injectable Antipsychotic Agents for the Treatment of Schizophrenia. [PDF]
Robinson DG+7 more
europepmc +1 more source
Correction: Clozapine, a Novel Antipsychotic Agent [PDF]
Olga Delgado Sánchez+1 more
openalex +1 more source
Abstract Background The coexistence of tics with Parkinson's disease (PD) is rare, as they often emerge at different ages, follow different trajectories and involve contrasting pathophysiological mechanisms related to dopamine availability and function in the brain. Cases We present 10 individuals with primary tic disorders who later developed PD.
Tarig Abkur+11 more
wiley +1 more source
Risk of Drug-induced Movement Disorders with Newer Antipsychotic Agents. [PDF]
Kannarkat GT, Caroff SN, Morley JF.
europepmc +1 more source
The agonist activities of the putative antipsychotic agents, L‐745,870 and U‐101958 in HEK293 cells expressing the human dopamine D4.4 receptor [PDF]
Lucien Gazi+9 more
openalex +1 more source